Примери за използване на Benefit outweighs на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Avoided. If the benefit outweighs.
The innumerable detailed analyzes of the product clearly guarantee that the great additional benefit outweighs.
Actos, the benefit outweighs the identified risk.
Pradaxa should only be given if the benefit outweighs bleeding risks.
If the benefit outweighs the risk, co-administration of bedaquiline with Kaletra must be done with caution.
Хората също превеждат
Ospemifene should only be continued as long as the benefit outweighs the risk.
CellCept, the benefit outweighs the identified risk.
Zinacef should be prescribed to pregnant women only if the benefit outweighs the risk.
However, if the benefit outweighs the risk, co-administration of bedaquiline with ritonavir must be done with caution.
Zinnat should be prescribed to pregnant women only if the benefit outweighs the risk.
If the benefit outweighs the risk, SIRTURO may be used with caution when co-administered with lopinavir/ritonavir.
Who have a detectable plasma HIV-1 RNA unless the benefit outweighs the risk.
If the benefit outweighs the risk, co-administration of bedaquiline with Lopinavir/Ritonavir Mylan must be done with caution.
Then it is up to you to decide for yourself if the benefit outweighs the risk.
Treatment is continued while the benefit outweighs the risk of bleeding, which depends on the condition being treated and any existing risk factors.
According to the detailed examination of the product,we can no doubt conclude that the great added benefit outweighs.
If the combination is unavoidable,use can be considered if the benefit outweighs the risk with a close clinical monitoring.
Ceftriaxone should only be administered during pregnancy andin particular in the first trimester of pregnancy if the benefit outweighs the risk.
Therefore, the medicine should not be used in pregnancy unless benefit outweighs risk and it is considered necessary by the doctor.
These patients should be carefully assessed before prescribing Spravato andtreatment initiated only if the benefit outweighs the risk.
Therefore, the CHMP's view was that, as for Neupogen, the benefit outweighs the identified risks and recommended that it be approved for use in the EU.
Cubicin should only be used in such patients when it is considered that the expected clinical benefit outweighs the potential risk.
Therefore, the Agency's view was that, as for Humira, the benefit outweighs the identified risk, and it recommended that Cyltezo be given marketing authorisation.
That vaccination with MMRV vaccines may be considered in patients with selected immune deficiencies when the benefit outweighs the risk of vaccination.
Therefore, the Agency's view was that, as for MabThera, the benefit outweighs the identified risk and it recommended that Rituzena be given marketing authorisation.
Only initiate treatment with Spravato in patientswith clinically significant or unstable cardiovascular or respiratory conditions if the benefit outweighs the risk.
For patients on haemodialysis, TIENAM is recommended only when the benefit outweighs the potential risk of seizures(see section 4.2).
If the benefit outweighs the risk and a strong or moderate CYP3A4 inducer must be used, monitor patient closely for lack of efficacy(see sections 4.3 and 4.4).
Dexamethasone should be prescribed during pregnancy andparticularly in the first trimester only if the benefit outweighs the risks for the mother and child.
Therefore, the Agency's view was that, as for MabThera, the benefit outweighs the identified risk and it recommended that Blitzima be given marketing authorisation.